Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
-
Catheter Cardiovasc Interv · Jul 2007
Case ReportsPort-a-Cath perforation of the right atrium closed with an amplatzer ASD occluder.
Right atrial perforation can lead to tamponade and death. Closure devices are used for sealing of shunts in the heart. We describe an indwelling catheter that caused perforation of the right atrium and was treated with a percutaneous closure device.
-
Catheter Cardiovasc Interv · Jul 2007
Percutaneous rheolytic thrombectomy for large pulmonary embolism: a promising treatment option.
Pulmonary embolism (PE) is a common cardiovascular disease with significant mortality. Some patients with large PE are not eligible for current treatment options such as thrombolysis or surgical embolectomy. We report our experience of percutaneous rheolytic thrombectomy (PRT) using the AngioJet system combined with adjunctive local thrombolytic therapy and inferior vena cava (IVC) filter placement to treat massive or submassive PE in patients ineligible for current treatment options. ⋯ Percutaneous rheolytic thrombectomy using the AngioJet may be a treatment option for patients with massive or submassive PE who may not be eligible for thrombolytic therapy or surgical embolectomy.
-
Catheter Cardiovasc Interv · Jun 2007
Multicenter StudyAccess site hematoma requiring blood transfusion predicts mortality in patients undergoing percutaneous coronary intervention: data from the National Heart, Lung, and Blood Institute Dynamic Registry.
To determine both the etiology of and outcomes associated with access site hematoma requiring transfusion (HRT) in patients undergoing percutaneous coronary intervention (PCI). ⋯ Access site complications, especially HRT, remain a very important predictor of adverse procedural success and patient outcome.
-
Catheter Cardiovasc Interv · Jun 2007
Clinical TrialNew distal embolic protection device the FiberNet 3 dimensional filter: first carotid human study.
Evaluate the performance and safety of the FiberNet Embolic Protection System during carotid artery intervention. ⋯ The first human use of this new novel EPD in carotid artery stenting is encouraging. The FiberNet was easy to use and confirmed the ability to capture particles less than 100 microm. The feasibility of the FiberNet has been demonstrated. Additional patients will demonstrate the overall safety and efficacy of this new EPD device.